We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

SLAS Europe 2018 International Conference & Exhibition

Visit us at Booth #316 to see what’s new in HTS Assays and find answers to your drug screening questions.

  •  Brussels, Belgium | Square Meeting Center.
  •  Wednesday, June 27, 2018 – Friday, June 29, 2018

We’re ready to consult with your assay development and drug discovery challenges and questions. We want to hear about your successes too!

Bring your drug screening questions to Booth #316.
Daily prize drawings!
Lucky Dip Prizes

We invite you to join us for these talks.

Chris Eggers
Monitoring Protein Dynamics at Endogenous Levels with a Luminescent Peptide Tag
Presented by:
Chris Eggers, Sr Research Scientist, Promega Corporation
Workshop:
Thursday, June 28, 8.30-10:00 am, Studio 311
 
View Abstract
James Vasta
A Quantitative Target Engagement Approach to Profile Thermodynamic and Kinetic Selectivity in Live Cells
Presented by:
James Vasta, Research Scientist, Promega Corporation
Thursday, June 28, 10.30-12:45 am, Copper Hall, in the Future SAR Screening - Towards Better Drug Candidates Session!

Poster Session

Terry Riss
Technologies
Cells, Organoids and Tissues

SLAS-1183
New Sensitive Luminescent LDH-Release Assay that Enables "Real-Time" Sampling from Individual 3D Microtissues
Presented by:
Terry Riss, Global Strategic Marketing Manager, Promega Corporation
Steven Edenson
Discovery,
Early Discovery

SLAS-1192
Deciphering Key Cancer and Inflammation Signaling Pathways with Homogeneous Bioluminescent Cell Based Kinase Activity Assays
Technologies
Cells, Organoids and Tissues

SLAS-1252
Monitoring Functional Mechanisms of Protein Degradation in Living Cells
Presented by:
Steven Edenson, Strategic Collaborations Manager, Promega Corporation

Share With a Friend

We will NOT sell your personal information, such as your name or email address, to third parties or use your email address to send you marketing materials. The email and names entered will only be used to identify the sender and recipient of the email.

Send Cancel